Catalyst Wire Dossier Catalyst Wire Dossier

IL13Rα2 CAR-T Cells secreting anti-PD-L1 antibody

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IL13Rα2 CAR-T Cells secreting anti-PD-L1 antibody, covering 2026-03-19 to 2026-03-19. Get the full timeline:

Most recent: Clinical Trial Update: IL13Rα2 CAR-T Cells Secreting Anti-PD-L1 Antibody for Recurrent Malignant Glioma [Phase 1]

See pricing